Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by greaterfoolFredon May 30, 2021 7:26pm
261 Views
Post# 33294610

RE:RE:RE:Interim Financials

RE:RE:RE:Interim Financials
riverrrow wrote: 10 trial sites have managed to treat one patient in the past month. I'm not impressed.

I keep trying to tell you folks to curb your enthusiasm.  Some of you have unreasonable expectations.  This trial is a little more complicated than just a simple drug trial where you ship out some pills and a set of instructions.  We have to ship out sophisticated equipment, then send a technician to set it up and verify its operation.  Then we have to send someone to train Docs how to operate it and use it in treatment.  This all takes time, and with Covid, it takes more time than it should.  Have patience.  It will happen.  We need 35 to 40 treated so that we can throw out the first 12 who were undertreated and have a nice sample to submit to FDA.  Good luck all.
<< Previous
Bullboard Posts
Next >>